{
  "id": 499519,
  "title": "FDA rejects ITM's radiopharma drug over manufacturing problems",
  "url": "https://urgent.news/2026/08/10/fda-rejects-itms-radiopharma-drug-over-manufacturing-problems",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-10T19:05:00.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-rejects-itms-radiopharma-drug-over-manufacturing-problems/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA rejected ITM Isotope Technologies Munich’s radiopharmaceutical agent for neuroendocrine tumors because of manufacturing issues, delaying a potential challenger to Novartis’ approved drug Lutathera. ITM said the agency cited manufacturing ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment",
        "url": "https://urgent.news/2026/08/10/stat-in-surprise-decision-fda-rejects-radiopharma-therapy-expected-to",
        "published": "2026-08-10T15:11:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}